Seasonal dynamics of the phenolic constituents of the cones and leaves of oriental ( L.) reveal their anti-inflammatory biomarkers.

Journal: RSC advances
Published Date:

Abstract

In this study, the seasonal dynamics of the flavonoids in the cones and leaves of oriental ( L. Franco) as well as the anti-inflammatory activity of their extracts were investigated. The important chemical markers of the studied extracts were determined using untargeted HPTLC profiling, which was further utilized to assess the seasonality effect on the composition of these metabolites over three seasonal cycles. A quantitative HPTLC method was developed and validated for the identified chemical markers of oriental : hyperoside, quercetrin, isoscutellarein-7--β-xyloside, cupressuflavone, hinokiflavone, sotetsuflavone and isoscutellarein-8-methyl ether. The highest amounts of flavonoids were observed during the summer and winter seasons, where the leaves possessed higher contents of flavonoids compared to cones. Flavone glycosides are a major class of flavones encountered in leaves, while the cones mainly accumulated biflavones. The results showed that the effect of seasonal variation on the accumulation of flavonoids within the cones was less pronounced than in the leaves. The summer leaves showed a remarkable reduction in the levels of INF-γ, where the value decreased to 80.7 ± 1.25 pg mL, a significantly lower level than that obtained with piroxicam (180 ± 1.47 pg mL); this suggests a noteworthy anti-inflammatory potential. OPLS (orthogonal projection to latent structures) models showed that flavonoidal glycosides, quercetrin, hyperoside and isoscutellarein-7--β-xyloside were the most contributing biomarkers to the reduction in pro-inflammatory mediators in LPS-stimulated WBCs. The results obtained in the study can thus be exploited to establish the best organs as well as the optimal periods of the year for collecting and obtaining certain biomarkers at high concentrations to guarantee the efficacy of the obtained extracts.

Authors

  • Reham S Darwish
    Department of Pharmacognosy, Faculty of Pharmacy, Alexandria University Alkhartoom Square Alexandria 21521 Egypt shawkyeman@yahoo.com eman.m.shawky@alexu.edu.eg +20-34871668-4873273.
  • Hala M Hammoda
    Department of Pharmacognosy, Faculty of Pharmacy, Alexandria University Alkhartoom Square Alexandria 21521 Egypt shawkyeman@yahoo.com eman.m.shawky@alexu.edu.eg +20-34871668-4873273.
  • Doaa A Ghareeb
    Biological Screening and Preclinical Trial Laboratory, Department of Biochemistry, Faculty of Science, Alexandria University Alexandria Egypt.
  • Ali S A Abdelhamid
    Pharmaceutical and Fermentation Industries Development Centre, City of Scientific Research and Technological Applications (SRTA-City) Borg Al-Arab Alexandria Egypt.
  • Fathallah M Harraz
    Department of Pharmacognosy, Faculty of Pharmacy, Alexandria University Alkhartoom Square Alexandria 21521 Egypt shawkyeman@yahoo.com eman.m.shawky@alexu.edu.eg +20-34871668-4873273.
  • Eman Shawky
    Department of Pharmacognosy, Faculty of Pharmacy, Alexandria University Alkhartoom Square Alexandria 21521 Egypt shawkyeman@yahoo.com eman.m.shawky@alexu.edu.eg +20-34871668-4873273.

Keywords

No keywords available for this article.